FebriDx® Point-of-Care Rapid Test
$643.75
FebriDx® is a rapid point-of-care test that uses a fingerstick blood sample to aid in the differentiation between bacterial infection and non-bacterial etiology. It measures two key host-response biomarkers: CRP, an indicator of systemic inflammation, and MxA, a marker specific to acute viral infection. Together, these biomarkers provide clear, actionable insight to support timely and confident respiratory infection decision-making.
How it works
Collect Sample
Simple fingerstick test, no venipuncture required.
Apply to Device
Place blood sample directly on the FebriDx test strip
Wait for 10-15 Minutes
Lateral flow immunoassay processes automatically
Read Result
Clear visual result bacterial, or non-bacterial
Why Providers Choose Dx Direct?
Authorized & Preferred Distribution Partner
Direct alignment with Lumos Diagnostics — no gray market risk, no uncertainty
Dedicated FebriDx
Focus
Not a catalog reseller. One product. One mission. Deep expertise.
Low-Friction
Ordering
Streamlined purchasing designed for urgent care, EDs, and outpatient workflows
Subscription & Volume-Aligned Pricing
Predictable supply, reduced reordering burden, discounted pricing for committed usage
Education-First Support
Clear clinical context, onboarding guidance, and implementation support
Reimbursement & Documentation Resources
Practical support to help teams navigate billing and internal justification
Simplifying Point-of-Care Adoption
Supporting better decisions without adding complexity.
FebriDx is intended to support clinical decision-making and must be interpreted in the context of signs, symptoms, patient history, and clinical judgment. It does not identify a specific pathogen and is not a standalone diagnostic.
FebriDx® is manufactured by Lumos Diagnostics. Dx Direct serves as an authorized distribution channel and does not manufacture the product.
Office
© 2026. All Rights Reserved.
